Journal Guide

Scope and subject areas The Journal of Physiology publishes full-length research papers and Rapid Reports of particularly important work that merits accelerated publication. Techniques for Physiology, introduced in 2008, are short papers aimed at disseminating new techniques for physiological research. Articles solicited by the Editorial Board include Perspectives, Symposium Reports and Topical Reviews, which highlight areas of special physiological interest, and Classical Perspectives describing how classic papers published in The Journal have influenced current research. Letters to the Editor and Journal Club articles are also published. All categories of papers are subjected to the same review procedure. For full details on scope and subject areas covered click here.

The Journals of Gerontology were the first journals on aging published in the United States. The tradition of excellence in these peer-reviewed scientific journals, established in 1946, continues today. The Journals of Gerontology, Series A publishes within its covers the Journal of Gerontology: Biological Sciences and the Journal of Gerontology: Medical Sciences.JOURNAL OF GERONTOLOGY: BIOLOGICAL SCIENCES, Rafael de Cabo, PhD, EditorPublishes articles on the biological aspects of aging in areas such as biochemistry, biodemography, cellular and molecular biology, comparative and evolutionary biology, endocrinology, exercise sciences, genetics, immunology, morphology, neuroscience, nutrition, pathology, pharmacology, physiology, vertebrate and invertebrate genetics, and biological underpinnings of late life diseases.JOURNAL OF GERONTOLOGY: MEDICAL SCIENCES, Luigi Ferrucci, MD, PhD,Publishes articles representing the full range of medical sciences pertaining to aging. Appropriate areas include, but are not limited to, basic medical science, clinical epidemiology, clinical research, and health services research for professions such as medicine, dentistry, allied health sciences, and nursing. It publishes articles on research pertinent to human biology and disease. The following types of articles are published: 1) articles reporting original research; 2) rapid communications; 3) review articles; 4) guest editorials.

The Lancet Diabetes & Endocrinology, dedicated to covering the disciplines of diabetes, endocrinology, and metabolism, is the latest title in The Lancet family of specialty journals. Continuing in The Lancet's tradition of publishing high-impact content that influences medical practice, each monthly issue of The Lancet Diabetes & Endocrinology will contain Original Research, Reviews, Comments, and News.The Lancet Diabetes & Endocrinology is stringently edited and peer-reviewed to ensure the scientific merit and clinical relevance of its diverse content. Original Research is fast-tracked to publication within 8 weeks on average of submission and published Online First on TheLancet.com before the print issue.Gold or Green Open Access is available for research supported by selected funding agencies with whom Elsevier has an agreement. The journal is also freely available to readers in low-to-middle-income countries via the HINARI programme or via IP access at thelancet.com.The journal is now accepting submissions of Original Research, Review, and Personal Views. Visit http://ees.elsevier.com/thelancetde to learn more about our editorial scope and aims and to submit your manuscript.To find out more about The Lancet Diabetes & Endocrinology, visit http://www.TheLancet.com/diabetes-endocrinology

The aim of this journal is to cultivate, promote and encourage advancement ofscientific dedication in the field of cell and chromosome research  in eukaryotes- physical, chemical, structural and functional. The scope of the journal has been extended further on eukaryotic genomics covering molecular genetics – both nuclear and organellar, though no doubt the emphasis will always be on Chromosome Dynamics. It is beneficial for students, teachers,research workers and all others interested in the study of cytology, genetics, molecular genomics and evolution in eukaryotic systems.

Oncology and hematology professionals are continuously charged with staying on the cutting–edge of new medical treatments and technologies to foster better cancer patient care and practice management. To that end, The Oncologist® is dedicated to translating the latest research developments into best multimodality practice.Established by oncologists for oncologists, the Journal is committed to helping physicians excel in a challenging and ever-changing environment; to ensure their patients’ rights to the highest level of care from screening and prevention to diagnosis, treatment and management of the disease.Designed specifically for the busy practitioner, The Oncologist is devoted to medical and practice issues for surgical, radiation, and medical oncologists. With emphasis on clear, concise interpretation, rather than data, the Journal's articles are meant to impact the practice of oncology and to facilitate significant communication in the introduction and application of new advancements.The Oncologist'sSenior Editors believe that the various oncology subspecialists should share the same information base and read the same journal. It is up to us, as leaders in this field, to defend the patient's needs and rights and to assure that the patient has an advocate. In order to do so, we have to be united and fully informed. We pledge to put the best and latest information on cancer management before our readership, to help prepare them for the future, and to do their best as a team to improve outcomes and quality of life for every patient.Manuscripts are reviewed by two or more field experts and, when accepted, are published expeditiously—generally within 12 weeks. When a contribution is of such relevance as to significantly impact public health, authors may request Fast Track Review for a Rapid Communication, in which case an editorial decision will be made within 2 weeks of submission.The Oncologist challenges its readers to understand what is new and better, to glimpse the future, not only in terms of research, but also in terms of new team approaches to disease management. In short, we want our readers to explore how cancer medicine could be and will be practiced now and throughout the 21st century.CORRESPONDENCEEditorial correspondence, including submissions for publication or letters to the Editor, should be addressed to the Executive Editor. Submissions for publication in the Fundamentals in Cancer Medicine section should also be addressed to the Executive Editor.Information for Authors can be found at the back of each issue, or contact the AlphaMed Press Editorial Office.Advertising: Correspondence and rate requests should be addressed to the Publisher.Change of Address notices: Both the subscriber's old and new address should be e-mailed to AlphaMed Press at least one month in advance. You can also mail the information to: AlphaMed Press, c/o Cambey & West, PO Box 412, Congers, New York 10920-9914 USA.

The Plant Cell publishes novel research of special significance in plant biology, especially in the areas of cellular biology, molecular biology, genetics, development, and evolution. The primary criteria for publication are that the article provides new insight that is of broad interest to plant biologists, not only to specialists, and that the presentation of results is appropriate for a wide audience of plant biologists.The Plant Cell was founded on four key tenets: (1) to publish the most exciting, cutting-edge research in plant cellular and molecular biology, (2) to provide the most rapid turnaround time possible for reviewing and publishing a research paper, (3) to feature the highest quality reproduction of data, and (4) to provide, in the front section of the journal, a more interactive format for commentaries, opinion pieces, and the exchange of information and ideas in review articles, meeting reports, and insightful overviews of featured research papers.For information about library subscriptions, contact Suzanne Cholwek at ASPB Library Subscription Services. For information about the prices for individual subscriptions, which are available to members of the American Society of Plant Biologists, contact ASPB Member Services. You may also update your mailing address for subscriptions or membership contact information.

Publishing the best original research papers in all key areas of modern plant biology from the world's leading laboratories, The Plant Journal provides a dynamic forum for this ever growing international research community. Plant science research is now at the forefront of research in the biological sciences, with breakthroughs in our understanding of fundamental processes in plants matching those in other organisms. The impact of molecular genetics and the availability of model and crop species can be seen in all aspects of plant biology. For publication in The Plant Journal the research must provide a highly significant new contribution to our understanding of plants and be of general interest to the plant science community. All areas of plant biology are welcome and the experimental approaches used can be wide-ranging. While The Plant Journal recognizes the importance of biotechnology for plant improvement, it does not publish full research papers that do not provide fundamental advances in plant biology. Authors:.

Thyroid, the Official Journal of the American Thyroid Association, is the leading resource for thyroidologists, endocrinologists, and internal medicine specialists to stay abreast of current reviews, commentaries, and clinical management strategies on all aspects of thyroid disease and treatment.The Journal is an indispensable resource for endocrinologists to stay up to date on the latest studies on thyroid diseases (thyroid dysfunction, workup of thyroid nodules, management of thyroid cancer), and other common disorders encountered in endocrine practice.Relevant for researchers in cell biology (autoimmunity, signaling, and hormone action), physiology, carcinogenesis, development, and genetics, Thyroid is also critical to a wide range of specialties including: internal medicine, endocrine surgery, pediatrics, OB/GYN, radiology, nuclear medicine, and pathology.Entering its 21st year, Thyroid remains unique in blending basic papers, clinical studies, and patient-focused reports, and is:* The repository for the best peer-reviewed translational research and clinical management in the field, offering online ahead-of-print publication* Covers all aspects of thyroid disease from primary care to clinical research* Global in scope, providing access to the most current research worldwide* The exclusive source for the Authoritative and Updated ATA Guidelines for Managing Thyroid Disease.

Thyroid Research is devoted to all aspects of thyroid hormones and thyroid diseases and their interaction with the cardiovascular, pulmonary, gastroenterological, metabolic and nervous systems.

Tissue Antigens publishes full-length original articles, brief communications, commentaries and reviews covering all aspects of genetic control of immunity. The scope includes functional, biochemical, and genetic studies on molecules of the immune system, including cell surface receptors and their ligands, and encompassing cytokines, and chemokines, adhesion and co-stimulating molecules, antigen receptors such as TcR, NKR, CD1, PAMPs, Igs, and genes and products of the major histocompatibility complex including classical and non-classical HLA molecules. Papers should describe original research in vitro, or in animal models, or be clinical studies reflecting genetics of immunity in solid organ or bone marrow transplantation, autoimmunity, infectious immunity, allergy, tumour immunity, vaccine science, pregnancy and disease susceptibility. The journal emphasis is on understanding genetic control of immunity through:.

Aims & Scope: Tissue Barriers is the first international cross-disciplinary journal that focuses on the architecture, biological roles and regulation of tissue barriers and intercellular junctions. We publish high quality peer-reviewed articles that cover a wide range of topics including structure and functions of the intestinal, airway, renal, epidermal and other types of tissue barriers, biology of  blood-brain and blood-testis barriers, molecular composition and dynamics of epithelial and endothelial junctions, leukocyte, tumor cell and pathogen interactions with epithelial and endothelial layers, non-cellular components of tissue barriers, barrier dysfunctions in diseases and drug delivery across epithelial and endothelial barriers.

Tissue Barriers publishes several categories of articles including: Original Research Papers, Short Communications, Technical Papers, Reviews, Perspectives and Commentaries, Hypothesis and Meeting Reports. Reviews and Perspectives/Commentaries will typically be invited. We also anticipate to publish special issues that are devoted to rapidly developing or controversial areas of research. Suggestions for topics are welcome.

Tissue Barriers has several goals:

• To promote cross-disciplinary awareness and collaborations between researchers working with different types of epithelial and endothelial barriers and build a broad and cohesive worldwide community of scientists interesting in this exciting field.
• To comprehend the enormous complexity of tissue barriers and map cross-talks and interactions between their different cellular and non-cellular components.
• To highlight the roles of tissue barrier dysfunctions in human diseases and accelerate a search for pharmacological enhancers of tissue barriers as potential therapeutic agents.
• To understand and optimize drug delivery across epithelial and endothelial barriers.

Publication office: Taylor & Francis, Group, 530 Walnut Street, Suite 850, Philadelphia, PA 19106.